Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on September 15, 2025

New ‘Home and Soul Harmony’ Show Featuring a Fitness Guru and a Master Interior Designer is Designed to Feed the Soul
Evok Healthcare Marketing Shares Strategies for High-Value Healthcare Service Line Marketing and Revenue Growth
80% of Doctors Are Leaving Private Practice: New Marketing Agency Aims to Reverse the Trend
Jean Fallacara Joins Jupiter Neurosciences as Co-Chairman of the Scientific Advisory Board for Nugevia™
Diverse Biotech Inc. Initiates Regulation D Private Placement to Fund Accelerated Development of new Antibiotic Class
VitalHub Announces Change of Auditor
Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Supporting Heart Health in Our Communities
Graphy Demonstrates Expansion of Digital Dental Solutions at WDSS 2025
Parexel and Paradigm Health Partner to Expand Access and Efficiency in Clinical Trials
Cocrystal Pharma, Inc. Announces Closing of Up To $13 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
Dr. Barbara Knox Drives Pediatric Efforts to Improve Child Protection Nationwide
Nyxoah Files Patent Infringement Lawsuit Against Inspire Medical Systems, Inc.
Nyxoah Entame une Procédure Judiciaire pour Violation de Brevets Contre Inspire Medical Systems, Inc.
UPDATE – Kalaris Therapeutics Now Enrolling Phase 1b/2 Multiple Ascending Dose Study of TH103 in Neovascular Age-Related Macular Degeneration
Women’s Health Collective Canada Launches Vital Talks National Seminar Series with the Support of Vichy Laboratoires
L’Association canadienne pour l’équité en santé des femmes (ACESF) lance la série de séminaires nationaux Conversations vitales avec le soutien de Vichy Laboratoires
AdCare Rhode Island Appoints New Executive Director as Facility Expansion Nears Completion to Serve More People Struggling with Addiction
Kyverna Therapeutics to Highlight Interim Phase 2 Data from KYV-101 KYSA-6 Study in Myasthenia Gravis at AANEM 2025
Immune Thrombocytopenic Purpura Market to Grow at a Paltry CAGR of 1.9% During the Forecast Period (2025–2034) | DelveInsight

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions